Greenwich Lifesciences Inc
(GLSI)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 27,204 | 28,906 | 29,801 | 30,405 | 28,660 |
| TOTAL | $27,204 | $28,906 | $29,801 | $30,405 | $28,660 |
| Non-Current Assets | |||||
| Intangibles | 13 | 14 | 14 | 15 | 16 |
| TOTAL | $13 | $14 | $14 | $15 | $16 |
| Total Assets | $27,217 | $28,920 | $29,815 | $30,420 | $28,677 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 221 | 296 | 628 | 609 | 711 |
| Other current liabilities | 164 | 159 | 25 | 64 | 335 |
| TOTAL | $385 | $455 | $653 | $673 | $1,046 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $385 | $455 | $653 | $673 | $1,046 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 12,951 | 13,123 | 12,969 | 12,896 | 12,847 |
| Common Shares | 13 | 13 | 13 | 13 | 13 |
| Retained earnings | -33,648 | -31,287 | -30,424 | -29,674 | -29,077 |
| TOTAL | $26,832 | $28,464 | $29,163 | $29,747 | $27,631 |
| Total Liabilities And Equity | $27,217 | $28,920 | $29,815 | $30,420 | $28,677 |